- NantKwest's (NK +2.0%) affiliate and exclusively-licensed distributor of its proprietary off-the-shelf NK-92® natural killer cells, Brink Biologics, has licensed its natural killer-based bioanalytical testing solution, to Fresenius Kabi SwissBioSim.
- Brink Biologics offers NK-92 based cell lines as part of its Neukopanel portfolio for laboratory based bioanalytical testing.
NantKwest's NK-92 bioanalytical testing line licensed to Fresenius Kabi SwissBioSim
Recommended For You
About IBRX Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
IBRX | - | - |
ImmunityBio, Inc. |